GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 63.56
+1.66 (2.68%)
At close: Aug 21, 2026
GKB Ophthalmics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,498 | 1,491 | 1,090 | 882.54 | 754.75 | 709.38 |
Other Revenue | 5.16 | - | - | - | - | - |
| 1,503 | 1,491 | 1,090 | 882.54 | 754.75 | 709.38 | |
Revenue Growth | 30.40% | 36.77% | 23.49% | 16.93% | 6.40% | 24.72% |
Cost of Revenue | 1,076 | 1,069 | 740.14 | 603.45 | 482.01 | 453.76 |
Gross Profit | 426.66 | 421.86 | 349.73 | 279.09 | 272.73 | 255.62 |
Selling, General & Admin | 181.72 | 193.66 | 201.46 | 162.23 | 132.94 | 111.53 |
Other Operating Expenses | 134.72 | 142.15 | 177.77 | 111.07 | 102.94 | 94.55 |
Operating Expenses | 348.83 | 368.18 | 410.1 | 302.29 | 264.17 | 232.76 |
Operating Income | 77.83 | 53.68 | -60.37 | -23.2 | 8.56 | 22.85 |
Interest Expense | -15.74 | -18.27 | -15.73 | -13.85 | -12.95 | -11.14 |
Interest & Investment Income | 11.85 | 11.85 | 10.75 | 8.89 | 6.02 | 5.12 |
Earnings From Equity Investments | -1.2 | -0.59 | 1.83 | -0.59 | 0.33 | 0.91 |
Currency Exchange Gain (Loss) | 0.14 | 0.14 | 1.92 | 0.16 | 1.27 | 2 |
Other Non Operating Income (Expenses) | -6.87 | -6.87 | -6.19 | -1.21 | -2.42 | -1.85 |
EBT Excluding Unusual Items | 66.01 | 39.93 | -67.79 | -29.79 | 0.81 | 17.9 |
Gain (Loss) on Sale of Investments | - | - | - | 0 | - | 0.07 |
Gain (Loss) on Sale of Assets | 0.76 | 0.76 | 0.4 | 0.45 | 0.57 | -0.42 |
Other Unusual Items | -17.6 | -17.6 | 0.13 | 1.59 | 0 | 0.06 |
Pretax Income | 57.11 | 31.04 | -67.26 | -27.76 | 1.39 | 19.46 |
Income Tax Expense | 1.97 | 0.77 | 3.53 | 2.06 | 0.23 | 0.02 |
Earnings From Continuing Operations | 55.14 | 30.27 | -70.79 | -29.82 | 1.16 | 19.44 |
Minority Interest in Earnings | -22.71 | -18.09 | 0.34 | 1.72 | -2.84 | -6.7 |
Net Income | 32.44 | 12.19 | -70.45 | -28.11 | -1.67 | 12.74 |
Net Income to Common | 32.44 | 12.19 | -70.45 | -28.11 | -1.67 | 12.74 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 0.14% | - | - | - | - | 0.01% |
EPS (Basic) | 6.44 | 2.42 | -13.98 | -5.58 | -0.33 | 2.53 |
EPS (Diluted) | 6.44 | 2.42 | -13.98 | -5.58 | -0.33 | 2.53 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -48.34 | -55.77 | 21.44 | -39.87 | 3.11 |
Free Cash Flow Per Share | - | -9.59 | -11.06 | 4.25 | -7.91 | 0.62 |
Gross Margin | 28.38% | 28.30% | 32.09% | 31.62% | 36.14% | 36.03% |
Operating Margin | 5.18% | 3.60% | -5.54% | -2.63% | 1.13% | 3.22% |
Profit Margin | 2.16% | 0.82% | -6.46% | -3.19% | -0.22% | 1.80% |
Free Cash Flow Margin | - | -3.24% | -5.12% | 2.43% | -5.28% | 0.44% |
EBITDA | 110.22 | 85.77 | -29.51 | 5.78 | 36.83 | 49.52 |
EBITDA Margin | 7.33% | 5.75% | -2.71% | 0.66% | 4.88% | 6.98% |
D&A For EBITDA | 32.39 | 32.09 | 30.86 | 28.98 | 28.27 | 26.66 |
EBIT | 77.83 | 53.68 | -60.37 | -23.2 | 8.56 | 22.85 |
EBIT Margin | 5.18% | 3.60% | -5.54% | -2.63% | 1.13% | 3.22% |
Effective Tax Rate | 3.45% | 2.47% | - | - | 16.57% | 0.12% |
Revenue as Reported | 1,526 | 1,513 | 1,103 | 897.6 | 763.98 | 720.92 |
Advertising Expenses | - | 8.16 | 6.31 | 4.65 | 2.68 | 1.32 |